Publisher
Springer Science and Business Media LLC
Subject
Biochemistry, medical,Clinical Biochemistry,Endocrinology,Endocrinology, Diabetes and Metabolism
Reference34 articles.
1. Qi L, Ding X, Tang W, Li Q, Mao D, Wang Y. Prevalence and risk factors associated with dyslipidemia in Chongqing, China. Int J Environ Res and Public Health. 2015;12:13455–65.
2. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–47.
3. Houston M. Dyslipidemia. In: Integrative Medicine [Internet]. Elsevier; 2018 [cited 2019 Apr 4]. p. 264-75.e5. Available from:
https://linkinghub.elsevier.com/retrieve/pii/B978032335868200027X
.
4. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2:231–7.
5. Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities in the United States: the National Health and nutrition examination survey 2003–2006. J Clin Lipidol. 2012;6:325–30.
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献